Evidence map›Paper›PMID 40795963›Full record

ArticleNucleic acids research2025

Adaptive evolution of oriC through in vitro propagation of a mini-chromosome in RCR.

Shota Suzuki, Masayuki Su'etsugu

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shota SuzukiDepartment of Life Science, College of Science, Rikkyo University, 3-34-1 Nishi-Ikebukuro, Toshima-ku, Tokyo 171-8501, Japan.ORCID 0000-0001-7459-2529
Masayuki Su'etsuguDepartment of Life Science, College of Science, Rikkyo University, 3-34-1 Nishi-Ikebukuro, Toshima-ku, Tokyo 171-8501, Japan.

Funding

Grants-in-Aid for Scientific Research 23K05733Grants-in-Aid for Scientific Research 24K02007Japan Society for the Promotion of ScienceJST JPMJAP24B5JST JPMJCR18S6JST JPMJGX23B1
6 · The paper itself

Abstract

Diversification and selective propagation are the main driving forces of evolution, resulting in the emergence of organisms possessing various strategies. Here, we conducted in vitro evolution of the replication origin (oriC) under the pressure of an AT-rich mini-chromosome amplification using a reconstituted Escherichia coli replication-cycle reaction (RCR). Using next-generation sequencing, we identified that these evolved oriCs contain select mutations within the duplex unwinding element (DUE) and DnaA-binding site (DnaA box) regions, which are crucial for replication initiation. Real-time detection of RCR amplification (real-time RCR) revealed that the DUE mutations, which decreased the GC content, along with the introduction of a specific A/T sequence in DUE-M and a consecutive KAK (K = T or G) motif in DUE-R, enhanced the RCR amplification efficiency compared to the wild-type oriC (oriCwt). A competitive amplification assay also elucidated that the DnaA box mutations confer a competitive advantage over coexistent oriCwt. Although these DUE and DnaA box mutations were selected through the same amplification reaction, they exhibited distinct competitive amplification strategies. The DUE mutant represents a faster propagation strategy (r-strategy), while the DnaA box mutant represents an adaptive strategy with a competitive advantage (K-strategy), representing the r/K-selection theory in molecular evolution.

Indexed as

Chromosomes, BacterialDNA ReplicationEscherichia coliEvolution, MolecularReplication OriginBacterial ProteinsBase CompositionBinding SitesDNA, BacterialDNA-Binding ProteinsMutationBacterial ProteinsDnaA protein, BacteriaDNA, BacterialDNA-Binding Proteins

Identifiers

PMID40795963
PMCPMC12342881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.